A phase I study of IPH2101, a novel anti-inhibitory KIR monoclonal antibody, in patients with multiple myeloma

Abstract only

Saved in:
Bibliographic Details
Published inJournal of clinical oncology Vol. 28; no. 15_suppl; p. 8139
Main Authors Benson, D. M., Padmanabhan, S., Hofmeister, C. C., Bakan, C. E., Abonour, R., Suvannasankha, A., Efebera, Y. A., Squiban, P. J., Caligiuri, M. A., Farag, S.
Format Journal Article
LanguageEnglish
Published 20.05.2010
Online AccessGet full text

Cover

More Information
Summary:Abstract only
ISSN:0732-183X
1527-7755
DOI:10.1200/jco.2010.28.15_suppl.8139